Fundraising Fox
Christopher Whitfield
InvestorStrategic Advisor at 2Flo Ventures · Chief Executive Officer at Antigenix Therapeutics
Indianapolis, Indiana, United States
Find your path to Christopher
818 people in our graph share verified history with Christopher — schools, employers, funds. One of them is your warm intro.
Hyunki KimunlockedChristopher: together at Syridex Bio (2024–2026)
Christopher: together at Syridex Bio
Christopher: together at OneWe Reach (formerly WOCIP®)
Christopher: together at Santa Clara University Leavey School of Business
About
Christopher Whitfield is Chief Executive Officer of Antigenix Therapeutics, a spinout company developing antibody-based oncology therapies. He brings over 25 years of biopharmaceutical leadership experience, including 17 years at Eli Lilly and Company where he served as CEO of Eli Lilly South Africa, and a tenure as Executive Director and Regional General Manager for Africa at Gilead Sciences. Whitfield has founded and scaled multiple healthcare companies focused on African market expansion and also serves as an advisor to venture capital and private equity firms on healthcare transactions and strategy.
Chief Executive Officer at Antigenix Therapeutics
Experience
- Antigenix TherapeuticsChief Executive Officercurrent2024 — presentIndianapolis, Indiana, United States
- Temprian Oncology IncorporatedSenior Advisorcurrent2024 — present
- Syridex BioPartnercurrent2024 — present
- OneWe Reach (formerly WOCIP®)Member of the Board of Advisorscurrent2022 — presentGlobal
- Egg Healthy PregnancyCorporate Advisorcurrent2022 — present
- NeuroX1 Inc.Advisory Board Member2023 — 2025United States
- Gilead SciencesExecutive Director and General Manager, Africa Region2021 — 2023Africa
- African Clinical Research Organisation (Pty) LtdFounder, Member Board of Directors2007 — 2020Johannesburg Metropolitan Area
- Batswadi Group of CompaniesFounder, Chairman of the Board of Directors and Chief Executive officer2006 — 2018Africa
- EndeavorMember Board of Directors2008 — 2013South Africa
- Eli Lilly and CompanyCEO and General Manager2001 — 2005Johannesburg Metropolitan Area
- Eli Lilly and CompanyDirector1988 — 2001Greater Indianapolis
Skills & more
Biotechnology49Pharmaceuticals7Oncology47Business StrategyStrategic Planning62Marketing Strategy19Entrepreneurship88Product Development5New Business Development18Business Planning15Strategy Development1Research4
+8 more
Management ConsultingHealthcareSales ManagementLeadership DevelopmentCommercializationCross-functional Team LeadershipBusiness DevelopmentCompetitive Analysis- Member — YPO
- Agile Certified Professional — The International Consortium for Agility
From Christopher's professional profile.
Colleagues at 2Flo Ventures
Amanda Johnson
Venture Fellow at 2Flo Ventures
Amanda Waldhauser
Executive Director at Roivant Social Ventures at 2Flo Ventures
Angela James
Senior Advisor at 2Flo Ventures
Azurii Collier
Commercial Advisor at 2Flo Ventures
Brenda Ametepe
Venture Fellow at 2Flo Ventures
Charlotte Jones-Burton
Partner at 2Flo Ventures
Christina Broomes
Commercial Advisor at 2Flo Ventures
Deepak Malik
Director – Head, Capital at Alteria Capital
Frequently asked questions
- Who is Christopher Whitfield?
- Christopher Whitfield is Chief Executive Officer of Antigenix Therapeutics, a spinout company developing antibody-based oncology therapies. He brings over 25 years of biopharmaceutical leadership experience, including 17 years at Eli Lilly and Company where he served as CEO of Eli Lilly South Africa, and a tenure as Executive Director and Regional General Manager for Africa at Gilead Sciences. Whitfield has founded and scaled multiple healthcare companies focused on African market expansion and also serves as an advisor to venture capital and private equity firms on healthcare transactions and strategy.
- Where does Christopher Whitfield work?
- Christopher Whitfield is Strategic Advisor at 2Flo Ventures and Chief Executive Officer at Antigenix Therapeutics.
- Where did Christopher Whitfield go to school?
- Christopher Whitfield studied at Duke University - The Fuqua School of Business (MBA, Global Management); Boston University School of Public Health (Executive Education, Development of Global Health Outcomes); Santa Clara University Leavey School of Business (Black Corporate Board Readiness, Marketing).
Founder mafias
Duke University - The Fuqua School of Business mafia95
Also came through, then founded or led a company.
Jonathan ViolinM.B.A.Founded Viridian Therapeutics +2Corinna ChenMBAFounded Tierra Biosciences +1Melinda French GatesMaster of Business Administration - MBAFounded Gates Foundation +1Jacopo LeonardiMBAFounded 4D Path +1Christopher MortonMBAFounded SlidePay +1Lawrence GentilelloMaster of Business Administration (M.B.A.)Founded Optery +1
University of Cape Town mafia93
Also came through, then founded or led a company.
Daniel ChalefBachelor of Business ScienceFounded KnowledgeTree +1Kiaan PillayBachelor's DegreeFounded Stitch +1Tim ChambersBAFounded Offgrid +1Sean SandersBachelor of Business Science (Hons)Founded Revix +1Karl WestvigBBusSci (Hons)Founded Redwood +1Meg FaureBachelor of Science (B.Sc.)Founded Parent Sense +1
Santa Clara University Leavey School of Business mafia17
Also came through, then founded or led a company.
Wabash College mafia12
Also came through, then founded or led a company.
2Flo Ventures mafia3
Also came through, then founded or led a company.
Same school
Also attended Duke University - The Fuqua School of Business340
Dave BlivinMANAGING PARTNER at Cottonwood Technology FundBrooke BalcomBoard Member at CincyTechChad SummeBoard Member at CincyTechMatias BarberoVenture Partner at FJ LabsTracie RotterPartner, Platform at Lux CapitalUlili OnovakpuriManaging Partner at Kapor Capital
+ 334 more
Also attended Boston University School of Public Health10
Tay SalimullahVenture Partner at 4BIO CapitalAmy AinaDirector of Executive Operations at Founders Circle CapitalIsabel VinsonInvestor at Schooner CapitalMalyse UwaseSalient Advisory at i3 — Investing in Innovation AfricaBrock DanielsSenior Medical Director at IveeappPamela StephensonChief Commercial Officer at Disc Medicine
+ 4 more
Also attended Santa Clara University Leavey School of Business74
HowardAdvisor at Clear VenturesMary DentenChief Financial Officer at Scale Venture PartnersKristin DrewChief Financial Officer at CapitalGConnie ShengCo-Founder & Managing Director at Nautilus Ventures Management Company (Us), LlcGeorge ManuelianAdvisory Board Member at Rembrandt Venture PartnersJohn DelfinoPartner, General Counsel at TCV
+ 68 more
Also attended Wabash College22
Kyle PrifogleStaff AI Engineer at JMI EquityMichael KrutzPrincipal at Barrel VenturesMichael NogenPartner at Overton Venture CapitalMicah WalkerInvestment Associate at Innoventures IowaMatthew JessupAI & Digital Asset Analyst at Sarson FundsAman BrarFounding Partner at Ground Game Ventures
+ 16 more
Shared employers
Also worked at OneWe Reach (formerly WOCIP®)1
Also worked at Gilead Sciences55
Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesLan WuAnalyst at FusionAriel RahamimAn investor in pre-seed and idea stage startups
+ 49 more
Also worked at Endeavor347
Vinnie LauriaFounding Partner at Golden Gate VenturesAndrew GoldnerFounder & CEO at GrowthXSaraInvestor at Maven Ventures focused on consumer softwarePeter KellnerManaging Partner of Richmond GlobalLily SarafanInvestor at Streamlined VenturesPablo VenturaInvestor at Kfund
+ 341 more
Also worked at Eli Lilly and Company185
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital
+ 179 more